BR112022019246A2 - Usos de extratos de carum carvi e rosmarinus officinalis para reduzir inflamação e métodos para reduzir inflamação - Google Patents

Usos de extratos de carum carvi e rosmarinus officinalis para reduzir inflamação e métodos para reduzir inflamação

Info

Publication number
BR112022019246A2
BR112022019246A2 BR112022019246A BR112022019246A BR112022019246A2 BR 112022019246 A2 BR112022019246 A2 BR 112022019246A2 BR 112022019246 A BR112022019246 A BR 112022019246A BR 112022019246 A BR112022019246 A BR 112022019246A BR 112022019246 A2 BR112022019246 A2 BR 112022019246A2
Authority
BR
Brazil
Prior art keywords
reduce inflammation
methods
rosmarinus officinalis
carum carvi
officinalis extracts
Prior art date
Application number
BR112022019246A
Other languages
English (en)
Inventor
Mahmood Khalid
Brun Cecilia
P J Van Den Heuvel Antonius
Serrano Jose
Original Assignee
Johnson & Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc filed Critical Johnson & Johnson Consumer Inc
Publication of BR112022019246A2 publication Critical patent/BR112022019246A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00—Preparations for removing hair or for aiding hair removal
    • A61Q9/02—Shaving preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

USOS DE EXTRATOS DE CARUM CARVI E ROSMARINUS OFFICINALIS PARA REDUZIR INFLAMAÇÃO E MÉTODOS PARA REDUZIR INFLAMAÇÃO. São fornecidas composições que compreendem extrato de semente de Carum carvi; extrato de Rosmarinus officinalis; e um veículo farmacêutica e/ou cosmeticamente aceitável. São fornecidos, também, métodos para uso dos mesmos.
BR112022019246A 2020-03-26 2021-03-25 Usos de extratos de carum carvi e rosmarinus officinalis para reduzir inflamação e métodos para reduzir inflamação BR112022019246A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063000402P 2020-03-26 2020-03-26
PCT/IB2021/052490 WO2021191840A1 (en) 2020-03-26 2021-03-25 Compositions comprising carum carvi and rosmarinus officinalis extracts and methods of using same

Publications (1)

Publication Number Publication Date
BR112022019246A2 true BR112022019246A2 (pt) 2023-02-14

Family

ID=75278313

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022019246A BR112022019246A2 (pt) 2020-03-26 2021-03-25 Usos de extratos de carum carvi e rosmarinus officinalis para reduzir inflamação e métodos para reduzir inflamação

Country Status (8)

Country Link
US (1) US20210299203A1 (pt)
EP (1) EP4125980A1 (pt)
JP (1) JP2023520654A (pt)
CN (1) CN115768453A (pt)
AU (1) AU2021243854A1 (pt)
BR (1) BR112022019246A2 (pt)
CA (1) CA3176132A1 (pt)
WO (1) WO2021191840A1 (pt)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2507477A1 (fr) 1981-06-12 1982-12-17 Roussel Uclaf Nouveau procede de preparation d'un extrait de feuilles d'olea europea riche en oleuropeine, produits obtenus, application a titre de medicaments et compositions les renfermant
CH688787A5 (de) * 1995-09-05 1998-03-31 Dieter Linsig Etherische Oele enthaltende Zusammensetzungen.
IT1298283B1 (it) 1998-02-19 1999-12-20 B & T S R L Uso dell'estratto delle foglie di olea europea come antiradicalico
US7442391B2 (en) 2002-01-25 2008-10-28 Integrated Botanical Technologies, Llc Bioactive botanical cosmetic compositions and processes for their production
AU2003282358A1 (en) * 2002-11-21 2004-06-15 J.P.M.E.D. Ltd. Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil
ES2652603T3 (es) 2004-01-12 2018-02-05 Isp Investments Llc Composiciones bioactivas de plantas de Theacea y procedimientos para su producción y uso
US7452547B2 (en) 2004-03-31 2008-11-18 Johnson&Johnson Consumer Co., Inc. Product for treating the skin comprising a polyamine microcapsule wall and a skin lightening agent
JP4732337B2 (ja) * 2004-04-27 2011-07-27 高砂香料工業株式会社 毛髪用化粧料組成物
NZ607880A (en) 2006-02-21 2014-11-28 Akzo Nobel Surface Chemistry Llc Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production
US20090241242A1 (en) 2008-03-31 2009-10-01 Heidi Beatty Facial mask
BR112012013329A2 (pt) * 2009-12-04 2016-03-01 Colgate Palmolive Co composição oral e método para o tratamento de uma doença ou condição do tecido mole da cavidade oral
ITRM20120453A1 (it) * 2012-09-21 2014-03-22 Aboca Spa Societa Agricola Nuovi estratti di incenso e loro usi.
CN103102384B (zh) * 2012-12-30 2015-08-26 中山百灵生物技术有限公司 一种从迷迭香中提取高纯度熊果酸的方法
JP2016006036A (ja) * 2014-05-26 2016-01-14 アークレイ株式会社 ＡＧＥｓ分解剤およびその用途
CN104013784A (zh) * 2014-06-27 2014-09-03 周宇晨 一种治疗盆腔炎的药剂
US20180064775A1 (en) * 2015-03-18 2018-03-08 Anjon Biologics, Inc. Anti-pathogenic compositions
MX2018015583A (es) * 2016-06-15 2019-05-16 Ojai Energetics Pbc Metodos y composiciones para reducir el estres oxidativo.

Also Published As

Publication number Publication date
EP4125980A1 (en) 2023-02-08
CN115768453A (zh) 2023-03-07
WO2021191840A1 (en) 2021-09-30
AU2021243854A1 (en) 2022-10-20
US20210299203A1 (en) 2021-09-30
CA3176132A1 (en) 2021-09-30
JP2023520654A (ja) 2023-05-18

Similar Documents

Publication Publication Date Title
ECSP22047876A (es) Derivados de pirazolilo ?tiles como agentes anticancer?genos
CO2022008969A2 (es) Tetrahidrofuranos sustituidos como moduladores de canales de sodio
PA8639701A1 (es) Composicion del anticuerpo her2
CL2019002190A1 (es) Reducción de la viscosidad de formulaciones farmacéuticas que comprende una proteína terapéutica a una concentración de al menos 70 mg/ml, donde la proteína terapéutica no es un anticuerpo (divisional solicitud 201700984)
ECSP11005768A (es) Derivados de azol-pirimidina condensados
CU20210077A7 (es) Extractos bacterianos estables como fármacos
BR112021017350A2 (pt) Combinação de conjugado de anticorpo-derivado de pirrolobenzodiazepina e inibidor de parp
CL2020001821A1 (es) Formulación de adenovirus del grupo b.
BR112022010754A2 (pt) Análogos de rapamicina e usos dos mesmos
ECSP22043592A (es) Inhibidores de egfr alost?ricos y m?todos de uso de los mismos
CO2023006684A2 (es) Anticuerpos contra sars-cov-2 y usos de los mismos
BR112022002720A2 (pt) Formulações de conjugados de benzazepinas e usos das mesmas
BR112022013678A2 (pt) Quelatos macrocíclicos e seus usos
CO2023013050A2 (es) Composiciones de psilocibina, métodos para prepararlas y métodos de uso de estas
AR115359A1 (es) Preparaciones microbianas para plantas, composiciones y formulaciones que las comprenden y sus usos
CL2022002699A1 (es) Métodos para tratar la esclerosis múltiple recidivante utilizando un inhibidor de la tirosina cinasa de bruton.
CL2023000491A1 (es) Composiciones de erenumab y usos de las mismas (divisional de solicitud n° 02519-2020).
BR112022019246A2 (pt) Usos de extratos de carum carvi e rosmarinus officinalis para reduzir inflamação e métodos para reduzir inflamação
MX2021012353A (es) Composicion cosmetica topica y usos de la misma.
AR123861A1 (es) Politerapia de antagonistas de unión al eje pd-1 e inhibidores de lrrk2
BR112022019333A2 (pt) Composições compreendendo extratos de carum carvi e rosmarinus officinalis, e métodos para uso dos mesmos
CL2020002641A1 (es) Composición para modular genes responsables de las funciones generales de la piel, que comprende un extracto vegetal de cichorium intybus y ceramidas de pasionaria (divisional de la solicitud 03354-2018)
BR112022010143A2 (pt) Inibidores de ahr e usos respectivos
CO2023000130A2 (es) Composición y método para el tratamiento del dolor crónico
CO2022015428A2 (es) Compuesto de oxofenilarsina deuterada y uso del mismo

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25G Requested change of headquarter approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)